These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 14999361)
1. Endoscopic evaluation of the effects of indobufen and aspirin in healthy volunteers. Marzo A; Crestani S; Fumagalli I; Giusti A; Lowenthal DT Am J Ther; 2004; 11(2):98-102. PubMed ID: 14999361 [TBL] [Abstract][Full Text] [Related]
2. A prostacyclin-sparing effect of indobufen vs. aspirin. De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417 [TBL] [Abstract][Full Text] [Related]
3. Indobufen: an updated review of its use in the management of atherothrombosis. Bhana N; McClellan KJ Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445 [TBL] [Abstract][Full Text] [Related]
4. Comparison of aspirin and indobufen in healthy volunteers. Lee JY; Sung KC; Choi HI Platelets; 2016; 27(2):105-9. PubMed ID: 26083594 [TBL] [Abstract][Full Text] [Related]
5. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
6. Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs. Yeomans ND; Hawkey CJ; Brailsford W; Naesdal J Curr Med Res Opin; 2009 Nov; 25(11):2785-93. PubMed ID: 19788350 [TBL] [Abstract][Full Text] [Related]
7. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration]. Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969 [TBL] [Abstract][Full Text] [Related]
8. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease. Wiseman LR; Fitton A; Buckley MM Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938 [TBL] [Abstract][Full Text] [Related]
9. [Chronic treatment of vascular diseases with indobufen]. Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803 [TBL] [Abstract][Full Text] [Related]
10. Bleeding time and antiplatelet agents in normal volunteers. Pogliani EM; Fowst C; Bregani R; Corneo G Int J Clin Lab Res; 1992; 22(1):58-61. PubMed ID: 1633323 [TBL] [Abstract][Full Text] [Related]
11. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis. Cataldo G; Heiman F; Lavezzari M; Marubini E Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928 [TBL] [Abstract][Full Text] [Related]
12. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib. Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897 [TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Lanza FL; Rack MF; Simon TJ; Quan H; Bolognese JA; Hoover ME; Wilson FR; Harper SE Aliment Pharmacol Ther; 1999 Jun; 13(6):761-7. PubMed ID: 10383505 [TBL] [Abstract][Full Text] [Related]
15. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Dammann HG; Burkhardt F; Wolf N Aliment Pharmacol Ther; 1999 Aug; 13(8):1109-14. PubMed ID: 10468689 [TBL] [Abstract][Full Text] [Related]
16. Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. BarillĂ F; Pulcinelli FM; Mangieri E; Torromeo C; Tanzilli G; Dominici T; Pellicano M; Paravati V; Acconcia MC; Gaudio C Platelets; 2013; 24(3):183-8. PubMed ID: 22646157 [TBL] [Abstract][Full Text] [Related]
17. Long-term evaluation of indobufen in peripheral vascular disease. Belcaro G; De Simone P Angiology; 1991 Jan; 42(1):8-14. PubMed ID: 1992862 [TBL] [Abstract][Full Text] [Related]
18. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen. Bjarnason I; Macpherson A; Rotman H; Schupp J; Hayllar J Scand J Gastroenterol; 1997 Feb; 32(2):126-30. PubMed ID: 9051872 [TBL] [Abstract][Full Text] [Related]
20. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]